413 related articles for article (PubMed ID: 23117548)
61. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
[TBL] [Abstract][Full Text] [Related]
62. Frequent association of beta-catenin and WT1 mutations in Wilms tumors.
Maiti S; Alam R; Amos CI; Huff V
Cancer Res; 2000 Nov; 60(22):6288-92. PubMed ID: 11103785
[TBL] [Abstract][Full Text] [Related]
63. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.
da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S
Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934
[TBL] [Abstract][Full Text] [Related]
64. Wilms tumor: an update.
Al-Hussain T; Ali A; Akhtar M
Adv Anat Pathol; 2014 May; 21(3):166-73. PubMed ID: 24713986
[TBL] [Abstract][Full Text] [Related]
65. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
[TBL] [Abstract][Full Text] [Related]
66. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene.
Hu M; Zhang GY; Arbuckle S; Graf N; Shun A; Silink M; Lewis D; Alexander SI
Nephrol Dial Transplant; 2004 Jan; 19(1):223-6. PubMed ID: 14671061
[TBL] [Abstract][Full Text] [Related]
67. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
68. Two distinct WT1 mutations identified in patients and relatives with isolated nephrotic proteinuria.
Guaragna MS; Lutaif AC; Piveta CS; Belangero VM; Maciel-Guerra AT; Guerra G; De Mello MP
Biochem Biophys Res Commun; 2013 Nov; 441(2):371-6. PubMed ID: 24161391
[TBL] [Abstract][Full Text] [Related]
69. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
[TBL] [Abstract][Full Text] [Related]
70. Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms.
Li Y; Wang J; Li X; Jia Y; Huai L; He K; Yu P; Wang M; Xing H; Rao Q; Tian Z; Tang K; Wang J; Mi Y
Oncol Rep; 2014 Dec; 32(6):2680-6. PubMed ID: 25310451
[TBL] [Abstract][Full Text] [Related]
71. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
[TBL] [Abstract][Full Text] [Related]
72. Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.
Lehnhardt A; Karnatz C; Ahlenstiel-Grunow T; Benz K; Benz MR; Budde K; Büscher AK; Fehr T; Feldkötter M; Graf N; Höcker B; Jungraithmayr T; Klaus G; Koehler B; Konrad M; Kranz B; Montoya CR; Müller D; Neuhaus TJ; Oh J; Pape L; Pohl M; Royer-Pokora B; Querfeld U; Schneppenheim R; Staude H; Spartà G; Timmermann K; Wilkening F; Wygoda S; Bergmann C; Kemper MJ
Clin J Am Soc Nephrol; 2015 May; 10(5):825-31. PubMed ID: 25818337
[TBL] [Abstract][Full Text] [Related]
73. Wilms' tumor suppressor gene mutations in girls with sporadic isolated steroid-resistant nephrotic syndrome.
Yang YH; Zhao F; Feng DN; Wang JJ; Wang CF; Huang J; Nie XJ; Xia GZ; Chen GM; Yu ZH
Genet Mol Res; 2013 Dec; 12(4):6184-91. PubMed ID: 24338413
[TBL] [Abstract][Full Text] [Related]
74. Characterization of 17.94, a novel anaplastic Wilms' tumor cell line.
Brown KW; Charles A; Dallosso A; White G; Charlet J; Standen GR; Malik K
Cancer Genet; 2012 Jun; 205(6):319-26. PubMed ID: 22749038
[TBL] [Abstract][Full Text] [Related]
75. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
[TBL] [Abstract][Full Text] [Related]
76. β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma.
Lu LC; Shao YY; Lee YH; Hsieh MS; Hsiao CH; Lin HH; Kao HF; Ma YY; Yen FC; Cheng AL; Hsu CH
Oncology; 2014; 87(3):159-66. PubMed ID: 25012536
[TBL] [Abstract][Full Text] [Related]
77. Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.
Satoh Y; Nakagawachi T; Nakadate H; Kaneko Y; Masaki Z; Mukai T; Soejima H
J Biochem; 2003 Mar; 133(3):303-8. PubMed ID: 12761165
[TBL] [Abstract][Full Text] [Related]
78. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis.
Melo KF; Martin RM; Costa EM; Carvalho FM; Jorge AA; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Jun; 87(6):2500-5. PubMed ID: 12050205
[TBL] [Abstract][Full Text] [Related]
79. [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].
Wang HY; Sun LZ; Yue ZH; Yang J; Jiang XY; Mo Y
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):855-8. PubMed ID: 23302619
[TBL] [Abstract][Full Text] [Related]
80. A novel Wilms' tumor 1 gene mutation in a child with severe renal dysfunction and persistent renal blastema.
Wagner N; Wagner KD; Afanetti M; Nevo F; Antignac C; Michiels JF; Schedl A; Berard E
Pediatr Nephrol; 2008 Sep; 23(9):1445-53. PubMed ID: 18516627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
